Literature DB >> 33357221

Comparative in vitro analysis of inhibition of rhinovirus and influenza virus replication by mucoactive secretolytic agents and plant extracts.

Christin Walther1, Kristin Döring1, Michaela Schmidtke2.   

Abstract

BACKGROUND: Rhinoviruses and influenza viruses cause millions of acute respiratory infections annually. Symptoms of mild acute respiratory infections are commonly treated with over-the-counter products like ambroxol, bromhexine, and N-acetyl cysteine, as well as of thyme and pelargonium extracts today. Because the direct antiviral activity of these over-the-counter products has not been studied in a systematic way, the current study aimed to compare their inhibitory effect against rhinovirus and influenza virus replication in an in vitro setting.
METHODS: The cytotoxicity of ambroxol, bromhexine, and N-acetyl cysteine, as well as of thyme and pelargonium extracts was analyzed in Madin Darby canine kidney (MDCK) and HeLa Ohio cells. The antiviral effect of these over-the-counter products was compared by analyzing the dose-dependent inhibition (i) of rhinovirus A2- and B14-induced cytopathic effect in HeLa Ohio cells and (ii) of influenza virus A/Hong Kong/68 (subtype H3N2)- and A/Jena/8178/09 (subtype H1N1, pandemic)-induced cytopathic effect in MDCK cells at non-cytotoxic concentrations. To get insights into the mechanism of action of pelargonium extract against influenza virus, we performed time-of-addition assays as well as hemagglutination and neuraminidase inhibition assays.
RESULTS: N-acetyl cysteine, thyme and pelargonium extract showed no or only marginal cytotoxicity in MDCK and HeLa Ohio cells in the tested concentration range. The 50% cytotoxic concentration of ambroxol and bromhexine was 51.85 and 61.24 μM, respectively. No anti-rhinoviral activity was detected at non-cytotoxic concentrations in this in vitro study setting. Ambroxol, bromhexine, and N-acetyl cysteine inhibited the influenza virus-induced cytopathic effect in MDCK cells no or less than 50%. In contrast, a dose-dependent anti-influenza virus activity of thyme and pelargonium extracts was demonstrated. The time-of addition assays revealed an inhibition of early and late steps of influenza virus replication by pelargonium extract whereas zanamivir acted on late steps only. The proven block of viral neuraminidase activity might explain the inhibition of influenza virus replication when added after viral adsorption.
CONCLUSION: The study results indicate a distinct inhibition of influenza A virus replication by thyme and pelargonium extract which might contribute to the beneficial effects of these plant extracts on acute respiratory infections symptoms.

Entities:  

Keywords:  Acute respiratory infection; Ambroxol; Antiviral; Bromhexine; Mechanism; N-acetyl cysteine; Natural products; Over-the-counter medication; Pelargonium; Thyme; Virus

Year:  2020        PMID: 33357221      PMCID: PMC7757078          DOI: 10.1186/s12906-020-03173-2

Source DB:  PubMed          Journal:  BMC Complement Med Ther        ISSN: 2662-7671


  34 in total

Review 1.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

Review 2.  Antivirals targeting the polymerase complex of influenza viruses.

Authors:  Edin J Mifsud; Frederick G Hayden; Aeron C Hurt
Journal:  Antiviral Res       Date:  2019-06-25       Impact factor: 5.970

3.  Characteristics and management of patients with influenza in a German hospital during the 2014/2015 influenza season.

Authors:  Stefan Hagel; Katrin Ludewig; Anne Moeser; Michael Baier; Bettina Löffler; Benjamin Schleenvoigt; Christina Forstner; Mathias W Pletz
Journal:  Infection       Date:  2016-07-05       Impact factor: 3.553

4.  Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis.

Authors:  Qiang Wang; Na Yue; Mengyun Zheng; Donglei Wang; Chunxiao Duan; Xiaoge Yu; Xuefeng Zhang; Changjun Bao; Hui Jin
Journal:  Vaccine       Date:  2018-10-16       Impact factor: 3.641

Review 5.  Uncomplicated acute bronchitis.

Authors:  R Gonzales; M A Sande
Journal:  Ann Intern Med       Date:  2000-12-19       Impact factor: 25.391

6.  How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.

Authors:  Pernille Jorgensen; Jolita Mereckiene; Suzanne Cotter; Kari Johansen; Svetla Tsolova; Caroline Brown
Journal:  Vaccine       Date:  2017-12-26       Impact factor: 3.641

Review 7.  The hallmarks of COVID-19 disease.

Authors:  Daolin Tang; Paul Comish; Rui Kang
Journal:  PLoS Pathog       Date:  2020-05-22       Impact factor: 6.823

Review 8.  COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.

Authors:  Anshumali Mittal; Kavyashree Manjunath; Rajesh Kumar Ranjan; Sandeep Kaushik; Sujeet Kumar; Vikash Verma
Journal:  PLoS Pathog       Date:  2020-08-21       Impact factor: 6.823

Review 9.  The common cold.

Authors:  Terho Heikkinen; Asko Järvinen
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

Review 10.  The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.

Authors:  Judith M Rollinger; Michaela Schmidtke
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

View more
  3 in total

Review 1.  A Focused Insight into Thyme: Biological, Chemical, and Therapeutic Properties of an Indigenous Mediterranean Herb.

Authors:  Dalal Hammoudi Halat; Maha Krayem; Sanaa Khaled; Samar Younes
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

2.  Nutrition profile and potency of RGD motif in protein hydrolysate of green peas as an antifibrosis in chronic kidney disease.

Authors:  Meilinah Hidayat; Sijani Prahastuti; Muhammad Yusuf; Khomaini Hasan
Journal:  Iran J Basic Med Sci       Date:  2021-06       Impact factor: 2.699

3.  Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells.

Authors:  Jan Papies; Jackson Emanuel; Nicolas Heinemann; Žarko Kulić; Simon Schroeder; Beate Tenner; Martin D Lehner; Georg Seifert; Marcel A Müller
Journal:  Front Pharmacol       Date:  2021-10-25       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.